Rosanna Zhang

Rosanna Zhang has a diverse and extensive work experience. Rosanna began their career in 2017 as a Computational Biochemistry Researcher at the Massachusetts Institute of Technology. Rosanna then moved to Bank of America Merrill Lynch as a Sales and Trading, and also worked as a Kairos Fellow at the Kairos Society. In 2017, they became the Cofounder and COO of LindHealth. In 2018, they were a Fellow at .406 Ventures. In 2020, they were a Board Member at the United Nations. In 2021, they became the Head of Strategic Initiatives at ACROBiosystems, a global leader in recombinant protein and life sciences tools. In 2022, they became a Partner at Coho Deeptech. During their time at the China Development Bank Capital Fund of Fund, they analyzed healthcare venture capital, private equity funds, and direct investment opportunities. Rosanna also conducted due diligence of $50 million investment deals of European healthcare crossover fund and pre-IPO companies.

Rosanna Zhang holds a Bachelor's Degree from the Massachusetts Institute of Technology.